DSG2 and colon carcinoma: The effects of Dsg2 antibody and KC21 on ECFC angiogenesis inhibition are comparable to the application of Dsg2 antibody and EC2 domain peptides on disturbing intercellular barriers in human colon carcinoma (Caco) enterocytes [32].